BLFS
BioLife Solutions, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website biolifesolutions.com
- Employees(FY) 466
- ISIN US09062W2044
Performance
-3.92%
1W
+0.27%
1M
+13.32%
3M
+29.06%
6M
+61.23%
YTD
+103.57%
1Y
Profile
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; ultra-low temperature mechanical freezers; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Technical Analysis of BLFS 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-05 12:16
- 2024-12-03 19:00
BLFS: What does Argus have to say about BLFS?(Argus Research)
- 2024-11-26 19:00
BLFS: Raising target price to $24.00(Argus Research)
- 2024-11-19 17:40
- 2024-11-15 05:31
- 2024-11-14 16:05
- 2024-11-14 05:28
BioLife Solutions Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-11-14 03:05
- 2024-11-13 05:05
BioLife Solutions Q3 Loss Narrows, Revenue Rises(MT Newswires)
- 2024-11-13 02:16
- 2024-11-12 19:00
BLFS: Raising target price to $28.00(Argus Research)
- 2024-11-12 17:45
- 2024-11-12 16:05
- 2024-11-12 08:05
- 2024-11-12 03:05
- 2024-11-11 19:05
- 2024-11-11 07:11
- 2024-11-05 19:00
BLFS: Raising target price to $27.00(Argus Research)
- 2024-10-31 16:03
- 2024-10-31 04:03
- 2024-10-21 09:40
- 2024-10-09 17:55
- 2024-10-08 20:00
BLFS: What does Argus have to say about BLFS?(Argus Research)
- 2024-10-07 08:50
- 2024-10-03 09:40
- 2024-09-30 09:41
- 2024-09-20 17:44
- 2024-09-17 09:40
- 2024-09-05 06:53
- 2024-08-27 20:00
BLFS: What does Argus have to say about BLFS?(Argus Research)
Page 1 of 7
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.